Care pathway for patients hospitalized with venous thromboembolism
- PMID: 39817361
- PMCID: PMC11891819
- DOI: 10.1111/eci.14383
Care pathway for patients hospitalized with venous thromboembolism
Abstract
Background: Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a potentially fatal disease with a multifactorial nature, impacting different medical and surgical specialties. Recently, new guidelines and direct oral anticoagulants facilitated early discharge for most DVT patients and non-severe PE patients.
Objective: The aim of this study is to illustrate the distribution of VTE patients throughout the hospital and map their care pathway from Emergency Department (ED) to hospital discharge.
Methods: This multicenter retrospective cross-sectional study included all hospitalized patients with a VTE code from 39 hospitals between 2018 and 2019. Data were analysed using JupyterLab, with subgroup analyses based on mode of entry, diagnosis location and thrombosis site.
Results: A total of 23,199 hospitalizations were analysed, involving 17,718 patients a median age 66 years [52-78] and man-to-women ratio 1.05. Among these, 10,747(46.3%) had PE and 4176(18.0%) had lower limb DVT. The ED was the primary entry point for 31.2% of cases, followed by gastroenterology, surgery, geriatrics, and internal medicine. Patients admitted through ED patients were most frequently transferred to internal medicine, cardiovascular and intensive care units (ICU). The median hospital stay was 9 days [4-21], with ICU stays being the longest (mean 15 days [8-27]). Notably, 1357 patients (18.8%) of VTE patients were discharged within 48 h of ED admission.
Conclusions: This study is the first to portray the distribution and care pathways of VTE patients across hospital departments. Despite recent clinical guidelines, many patients still require inpatient management, highlighting the need for dedicated care pathway.
Keywords: care pathways; epidemiology; thrombosis; venous thromboembolism.
© 2025 The Author(s). European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.
Conflict of interest statement
I. Mahé has received personal fees from Bristol Myers Squibb, LEO Pharma, Sanofi and Pfizer and non‐financial support from Bristol Myers Squibb, LEO Pharma and grants from BMS Pfizer and Leo Pharma. Other authors declare no conflict of interest. Authors have no conflicts of interest related to the study design or its results.
Figures
References
-
- Brækkan SK, Hansen JB. VTE epidemiology and challenges for VTE prevention at the population level. Thrombosis Update. 2023;10:100132. doi:10.1016/j.tru.2023.100132 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
